Metagenomics and Non‐Targeted Metabolomics Reveal the Role of Gut Microbiota and Its Metabolites in Brain Metastasis of Non‐Small Cell Lung Cancer
Thoracic Cancer · 2025
DOI: 10.1111/1759-7714.70068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, 2025. Verfasst von Chen-Guang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Gastrointestinal Microbiome, Brain Neoplasms, Lung Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Talent Innovation Support Plan of Dalian, National Natural Science Foundation of China, The "1+X" program for Clinical Competency enhancement-Clinical Research Incubation Project of the Second Hospital of Dalian Medical University.
Abstract (Originalsprache)
Background
Brain metastasis is a common and severe complication in non‐small cell lung cancer (NSCLC) patients, significantly affecting prognosis. However, the role of gut microbiota and its metabolites in NSCLC brain metastasis remains poorly understood. This study aims to explore the relationship between gut microbiota, metabolites, and the development of brain metastasis in NSCLC.
Methods
We conducted an integrative analysis combining metagenomics and non‐targeted metabolomics on baseline fecal samples from NSCLC patients with brain metastasis ( n = 18) and those without distant metastasis ( n = 12). Gut microbiota composition and metabolite profiles were detected and analyzed, and statistical methods, including machine learning models, were applied to identify differences and potential biomarkers.
Results
Significant differences in gut microbiota composition were found between the two groups, with higher microbial diversity observed in patients with brain metastasis. Specific genera, such as Paenibacillus , Fournierella , and Adlercreutzia , were enriched in the brain metastasis group. Metabolomic analysis revealed altered levels of short‐chain fatty acids and other metabolites associated with immune modulation and vascular permeability, including angiotensin (1–7). These changes were linked to the metastatic process and may influence brain metastasis development. Furthermore, machine learning models identified key biomarkers, such as Raoultibacter , Mobilibacterium , and N ‐acetyl‐L‐glutamic acid, which could serve as valuable indicators for brain metastasis.
Conclusions
Our findings suggest that gut microbiota dysbiosis and its metabolic products may contribute to the development of brain metastasis in NSCLC. The identification of microbiota‐derived biomarkers holds potential for early detection and therapeutic intervention in NSCLC brain metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, China.
Förderung
- Science and Technology Talent Innovation Support Plan of Dalian
- National Natural Science Foundation of China
- The "1+X" program for Clinical Competency enhancement-Clinical Research Incubation Project of the Second Hospital of Dalian Medical University
- Natural Science Foundation of Liaoning Province
Zitieren
APA
Liu, C. G., Lin, M. X., Xin, Y., Sun, M., Cui, J., Liu, D., Zang, D., & Chen, J. (2025). Metagenomics and Non‐Targeted Metabolomics Reveal the Role of Gut Microbiota and Its Metabolites in Brain Metastasis of Non‐Small Cell Lung Cancer. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70068
Vancouver
Liu CG, Lin MX, Xin Y, Sun M, Cui J, Liu D, et al. Metagenomics and Non‐Targeted Metabolomics Reveal the Role of Gut Microbiota and Its Metabolites in Brain Metastasis of Non‐Small Cell Lung Cancer. Thoracic Cancer. 2025. doi:10.1111/1759-7714.70068
BibTeX
@article{Liu2025,
author = {Liu, Chen-Guang and Lin, Mei-Xi and Xin, Yu and Sun, Man and Cui, Jia and Liu, Dan and Zang, Dan and Chen, Jun},
title = {Metagenomics and Non‐Targeted Metabolomics Reveal the Role of Gut Microbiota and Its Metabolites in Brain Metastasis of Non‐Small Cell Lung Cancer},
journal = {Thoracic Cancer},
year = {2025},
doi = {10.1111/1759-7714.70068}
}
EUVIMED